Cell Surface Markers Market Size, Share, Growth, Trends, and Global Industry Analysis: By Instrument and Reagent Type (Flow Cytometer, Haematology Analysers, Reagents and Kits), By Application (Disease Diagnosis, Research and Drug Discovery) By End User (Hospitals, Home care, Ambulatory Care Centers) and Region Forecast 2020-2031

Cell Surface Markers Market size was valued at US$ 745.50 million in 2024 and is expected to reach US$ 1294.31 million by 2031, growing at a significant CAGR of 8.2% from 2025-2031. Bladder diseases is an umbrella term used to depict neurotic conditions that influence the structure or capacity of the bladder. Bladder ailments incorporate conditions identified with irritation, disease and urinary incontinence. This market is a remote therapeutic gadget that utilizations high-recurrence sound waves to produce a picture of the bladder of the individual. The major drivers of the global market includes expansion of human services innovation and decrease the cost of ailment determination.

The expansion in frequency of tumor and other immune system sickness fortifying the interest for the improvement of disentanglement of infections recognizable proof and the rising mechanization of arrangements and advancements are anticipated to fuel the market. Additionally, expanded research for the use of undeveloped cell innovation is profiting the part to develop. Nonetheless, the central point which are limiting cell surface markers identification developments are intricate items and costly instruments and reagents utilized as a part of cell marker investigation. The market is expected to gain huge traction due to advancements in fluorescence innovation, improvements of cytometric procedures. Presentation of fluorescence-enacted cell arranging (FACS) calculations for fast and quantitative examination of cells is foreseen to fuel industry development in future. Companies are focused on joint ventures with different players in the business to enhance market presence.

Key Developments:

• In April 2014, Beckman Coulter Life Sciences declared the securing of Xitogen Technologies, a cytometer producer. This securing encourages Beckman Coulter to expand its item contributions and empowers business development in Asia.